Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Mead Johnson Nutrition CO    MJN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Reckitt emerges as laggard in consumer goods sector

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2017 | 12:23pm CEST
Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic are seen in London

British consumer goods maker Reckitt Benckiser (>> Reckitt Benckiser Group Plc) failed to grow its underlying sales in the first three months of the year, blaming fallout from a South Korean safety scandal and a flop with a new Scholl product after figures fell short of estimates.

British consumer goods maker Reckitt Benckiser (>> Reckitt Benckiser Group Plc) failed to grow its underlying sales in the first three months of the year, blaming fallout from a South Korean safety scandal and a flop with a new Scholl product after figures fell short of estimates.

The like-for-like sales were the weakest in 15 years and shares of the maker of Durex condoms and Nurofen tablets fell 1.6 percent in London, while the FTSE 100 <.FTSE> was flat.

Analysts had expected the first quarter to be weak across the consumer goods sector, due to economic uncertainties and the timing of Easter.

But of the seven large companies to report this week -- including Nestle (>> Nestle SA), Unilever (>> Unilever plc) and Pernod Ricard (>> Pernod-Ricard) -- Reckitt is the first to miss expectations, said RBC Capital Markets analyst James Edwardes Jones.

"Not a disastrous miss ... but nonetheless things don't seem to be getting much easier for RB," Jones said in a note.

Reckitt however said sales would improve as the year goes on and stood by its target for annual growth of 3 percent.

The disappointing sales will however increase the focus on dealmaking which has seen Reckitt concentrate more on consumer health and flag a possible sale of its small food business.

The $16.6 billion (12.95 billion pounds) purchase of baby formula maker Mead Johnson (>> Mead Johnson Nutrition CO), announced in February, is progressing well, Reckitt said, and should be finalised by the end of September.

Reckitt said it would explore options for its food business before reaching any decision. It had said this month that it was reviewing a business it called "non-core" as it looks to pay down debt from Mead Johnson.

"TALE OF TWO HALVES"

Excluding the impact of currency fluctuations, acquisitions and disposals, Reckitt said first-quarter sales were flat, as increases in developing markets and in the hygiene business were not enough to offset declines in Europe and in the home products business.

Sales in Germany and Italy, for example, were lower than the year-ago period, when it launched the new Scholl "Wet & Dry Express pedi" foot file for hard skin, which failed to catch on.

Analysts on average were expecting growth of 1 percent, according to a consensus compiled by the company.

Aside from the failed foot file, which Chief Executive Rakesh Kapoor said was too expensive and too innovative, its business has suffered a collapse in South Korea.

Retailers have boycotted its products due to how it handled a safety scandal in which the government said 92 people were believed to have died from lung injuries related to humidifier sterilizers.

CEO Kapoor sought to convince analysts that there was nothing structural in the market or in the company's health business that should cause future weakness.

Kapoor repeated what he said in February, that this year 2017 would be "a tale of two halves" as the impacts of issues such as South Korea and India's demonetisation ease.

"We just have to go through this, knowing our underlying business is performing well," he said.

Reckitt also said it was in "active discussions" with the U.S. Department of Justice regarding litigation and investigations into the pharmaceutical business it spun off into Indivior (>> Indivior PLC) in 2014. It said it could not comment on any potential outcome or related costs.

(Reporting by Martinne Geller; Editing by Keith Weir)

By Martinne Geller

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEAD JOHNSON NUTRITION CO
04/27 MEAD JOHNSON NUTRITION : misses Street 1Q forecasts
04/27 MEAD JOHNSON NUTRITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
04/27 MEAD JOHNSON NUTRITION COMPANY (NYSE : MJN) Files An 8-K Results of Operations a..
04/27 MEAD JOHNSON NUTRITION CO : Results of Operations and Financial Condition, Finan..
04/27 MEAD JOHNSON NUTRITION : Reports First Quarter 2017 Results
04/25 DIRECTOR DEALINGS : Two Tesco Non-Executive Directors Buy Shares
04/21 Reckitt emerges as laggard in consumer goods sector
04/13 Morgan Stanley bags big spots on Unilever, Reckitt deals - sources
04/13 Reckitt working with Morgan Stanley on food business sale - sources
03/31 MEAD JOHNSON NUTRITION CO : Other Events, Financial Statements and Exhibits (for..
More news
Sector news : Baby Food
04/28DJMONDELEZ INTERNATIONAL : How BuzzFeed and Mondelez Brought Healthy Food Videos t..
04/27DJFrom Diapers to Soda, Big Brands Feel Pinch as Consumers Pull Back
04/26DJFrom Diapers to Soda, Big Brands Feel Pinch as Consumers Pull Back
04/26DJFrom Diapers to Soda, Big Brands Feel Pinch as Consumers Pull Back
04/26DJFrom Diaper to Soda Makers, Big Brands Feel the Pinch of a Consumer Pullback
More sector news : Baby Food
News from SeekingAlpha
04/28 RISK ARBITRAGE TODAY : Dutch Auction In CIT Group
04/27 Mead Johnson Nutrition misses by $0.06, misses on revenue
04/27 DIVIDEND STREAKS IN DANGER : 2016 Review And 2017 Preview
04/18 5 Reasons Investors Should Own More Mid-Cap Stocks
04/12 After The Failed Unilever Bid, Consider These Two Companies
Advertisement
Financials ($)
Sales 2017 3 633 M
EBIT 2017 848 M
Net income 2017 569 M
Debt 2017 994 M
Yield 2017 1,91%
P/E ratio 2017 28,66
P/E ratio 2018 26,53
EV / Sales 2017 4,76x
EV / Sales 2018 4,62x
Capitalization 16 293 M
More Financials
Chart MEAD JOHNSON NUTRITION CO
Duration : Period :
Mead Johnson Nutrition CO Technical Analysis Chart | MJN | US5828391061 | 4-Traders
Full-screen chart
Technical analysis trends MEAD JOHNSON NUTR...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 88,9 $
Spread / Average Target 0,19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Peter Kasper Jakobsen President, Chief Executive Officer & Director
James M. Cornelius Non-Executive Chairman
Charles M. Urbain Chief Operating Officer & Executive Vice President
Michel Martinus Gerardus Cup Chief Financial Officer, Treasurer & Executive VP
Dirk H. Hondmann Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEAD JOHNSON NUTRITION..25.38%16 293
NESTLE SA4.93%239 549
KRAFT HEINZ CO3.52%110 017
MONDELEZ INTERNATIONAL..1.58%68 648
DANONE6.61%45 855
GENERAL MILLS, INC.-6.90%33 134
More Results